Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06055296 · ClinicalTrials.gov registry record · NA
Multisite Implementation of COMPRENDO
A NA study of Pediatric Cancer, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 4
- Study locations
NCT06055296: Recruiting NA study of Pediatric Cancer, sponsored by University of California, San Diego.
NCT06055296 is a NA study of Pediatric Cancer that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 450 participants, below the 1,482-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (70% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06055296, a NA study of Pediatric Cancer, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 4
- Study locations
Study Summary
COMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform real-world setting implementation. This study will test the impact of COMPRENDO, a peer-navigation intervention, vs. usual care on accrual to childhood cancer therapeutic clinical trials and parental informed consent outcomes. COMPRENDO will be delivered by trained peer navigators in 4 visits. A mixed methods (surveys, individual interviews) implementation evaluation will examine implementation factors that can inform the use of peer navigation in clinical practice, integrating data from clinicians, navigators, administrators, and parents pre and post the RCT.
Primary Outcome
Measured by a higher proportion of children enrolled in therapeutic trials whose parents are randomized to COMPRENDO vs. the proportion of children enrolled in therapeutic trials whose parents are randomized to usual care.
Conditions Studied
Interventions
- OTHER COMPRENDO Peer Navigation Intervention
Study Locations (4)
California
- Rady Children's Hospital San Diego/University of California San Diego Moores Cancer Center - San Diego
- University of California San Francisco Benioff Children's Hospitals - San Francisco
Alabama
- Children's of Alabama/University of Alabama at Birmingham - Birmingham
Massachusetts
- Dana Farber Cancer Institute/Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2024-01-11 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
What NCT06055296 shows while recruiting
NCT06055296 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,482-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 1 intervention - of which COMPRENDO Peer Navigation Intervention is the first listed.
NCT06055296 reports a single indexed study location in California, Alabama, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06055296 about?
NCT06055296 is a clinical study titled "Multisite Implementation of COMPRENDO". COMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform real-world setting i...
What is the current status of trial NCT06055296?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2024-01-11. Estimated completion is 2029-06-30.
What conditions does trial NCT06055296 study?
This clinical trial studies the following conditions: Pediatric Cancer.
What interventions are being tested in trial NCT06055296?
The interventions under investigation include: COMPRENDO Peer Navigation Intervention (OTHER).
Who is sponsoring clinical trial NCT06055296?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06055296 being conducted?
This trial has 4 study locations across Alabama, California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06055296's enrollment target sits among peer trials
450 8th of 51 higher than 44 of 51 other Pediatric Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Digital Art Therapy for Young Cancer Survivors
RECRUITING · NA
-
Medically Tailored Meals for Kids
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
RECRUITING · NA
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI